Find Academic Supervisors

• Oral Surgery
• Maxillofacial Surgery
• Head and Neck Cancer
• +12 more

Martin Gosau is a Professor at the Clinic and Polyclinic for Oral and Maxillofacial Surgery within the Medical Faculty of the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on Oral Surgery , Maxillofacial Surgery , and Regenerative Medicine , with a strong emphasis on Dental Implants , Head and Neck Cancer , and Oral Pathology . University: University Medical Center Hamburg-Eppendorf School: Medical Faculty Department: Oral and Maxillofacial Surgery Academic Rank: Professor His recent work explores: Oral Health in Genetic Disorders (e.g., hypophosphatasia) Advanced Surgical Techniques (e.g., nanosecond lasers, fluorescence angiography) Biomaterials and Tissue Engineering (e.g., silk fibroin membranes, extracellular vesicles) Cancer Prognostics (e.g., DCBLD1 overexpression in HNSCC) Key trends in his 15 most recent articles include applications of machine learning in oral diagnostics, stem cell research for bone regeneration, and biomaterials in reconstructive surgery. He frequently collaborates with Ralf Smeets and Thomas Vollkommer , with publications spanning Frontiers in Immunology , Oral Surgery , and Scientific Reports .

Hanna TaipaleenmäkiView profile

Researcher

• Bone Physiology
• Cancer Biology
• MicroRNA Regulation
• +6 more

Dr. Hanna Taipaleenmäki is a Researcher and Group Leader at the Molecular Skeletal Biology Laboratory (MSB-Lab) within the University Medical Center Hamburg-Eppendorf in Hamburg, Germany. She holds a PhD from the University of Turku (Finland) and Odense University Hospital (Denmark), followed by postdoctoral research at the University of Massachusetts Medical School (USA) and UMC Hamburg-Eppendorf. Her research focuses on the role of osteoblasts in breast cancer-induced metastatic bone disease, particularly investigating microRNA regulation in bone physiology and pathology. Key areas include histomorphometry, in vivo models, and translational medicine. She is an active member of the ECTS and ASBMR scientific societies. Her work has been recognized through multiple awards and grants, though specific names are not listed. Technical strengths include in vivo methods and expertise in bone-cancer cross-talk mechanisms. Dr. Taipaleenmäki’s research aims to elucidate malignant interactions between bone and cancer cells in metastasis, with a focus on therapeutic targets in the bone microenvironment.

• Bone Metabolism
• Kidney Disease
• Transcriptional Regulation
• +5 more

Jackie A. Fretz, PhD, is a Researcher at Yale University's Yale School of Medicine, affiliated with the Department of Orthopaedics & Rehabilitation. She manages the Histology and Histomorphometry Laboratory and holds a PhD from the University of Wisconsin-Madison. Her research focuses on the transcription factor EBF1's role in cellular fate determination, particularly in bone, kidney, and adipocyte biology. She investigates how EBF1 regulates mesenchymal progenitors, marrow adipogenesis, and kidney glomerular development. Education: PhD in Biochemistry (University of Wisconsin-Madison, 2007); BS in Biochemistry and Molecular Biology (University of New Hampshire, 2002). Postdoctoral training at Yale School of Medicine (2011). Research interests include EBF1's actions in bone vasculature, renal pathophysiology, and metabolic pathways. Her work bridges bone and kidney diseases, revealing conserved mechanisms in mesenchymal cell regulation. Recent studies explore EBF1's role in fracture repair, chronic kidney disease-mineral bone disorders, and FGF23 regulation. Awards include the ASBMR Mid-Career Travel Grant (2022) and the American Society of Bone and Mineral Research President's Poster Award (2011). She has presented at international conferences such as the ASBMR Annual Meeting and the NIH Workshop on FGF-23. Laboratory: Orthopaedic Histology and Histomorphometry Laboratory, focused on histological techniques and skeletal research. Active in methodological advancements like methyl methacrylate embedding for bone analysis.

• Dentistry
• Periodontology
• Dental Implants
• +5 more

Dr. Ramzi Abou-Arraj is a tenured Professor and Interim Associate Dean at the University of Alabama at Birmingham School of Dentistry , where he has served since 2012. His academic appointments span Periodontology, the Global Center for Craniofacial Oral and Dental Disorders (GC-CODED), and the School of Medicine's Center for Clinical and Translational Science (CCTS). Education : Doctor of Dental Surgery (DDS) from Saint-Joseph University (2003), Certificate in Periodontics (2012), and Master of Science in Dental Clinical Sciences from UAB (2012). Dr. Abou-Arraj's research focuses on periodontal regeneration , bone augmentation techniques , and soft tissue grafting around dental implants. His work evaluates biomaterials (e.g., acellular dermal matrix, rh-FGF-2/β-TCP), anatomical factors in sinus surgery, and patient-centered outcomes in mucogingival procedures. Recent publications (2015-2023) demonstrate trends in bone particle size effects , wound dressing modalities , and peri-implant tissue management . He has secured extramural funding from NIH, Straumann, and Medtronic for clinical trials on implant complications and regenerative therapies. Scientific Awards : AADR William B. Clark Fellowship and AAPF Richard Lazzara Fellowship in Advanced Implant Surgery. As an educator, Dr. Abou-Arraj has taught graduate implantology, periodontology, and clinical integration courses since 2012. He has served on thesis committees for students researching implantology and mucogingival surgeries, while maintaining active roles in interdisciplinary clinical decision-making and curriculum development.

Mārtiņš VaivadsView profile

Assistant Professor

• Cleft Lip and Palate
• Craniofacial Anomalies
• Molecular Genetics
• +7 more

Mārtiņš Vaivads is an Assistant Professor at the Department of Morphology, Institute of Anatomy and Anthropology, Faculty of Medicine, Riga Stradins University. He also serves as Deputy Vice-Dean for International Students, reflecting his administrative engagement alongside academic responsibilities. His research centers on craniofacial development and anomalies, particularly non-syndromic cleft lip and palate. He investigates the molecular and genetic underpinnings of these conditions, focusing on homeobox genes, signaling pathways (SHH, WNT), and tissue-level changes involving inflammation, immunomodulation, and regeneration. His work contributes to the UN Sustainable Development Goal 3 (Good Health and Well-being) through fundamental medical research. The recent publications (2017–2025) highlight a consistent focus on immunohistochemical analysis of candidate genes and proteins in cleft-affected tissues. Key themes include the expression of BARX1, DLX4, FOXE1, HOXB3, MSX2, SOX3, PAX7, SHH, and WNT proteins, as well as factors involved in tissue protection and regeneration such as HSP60 and BMP2. His work bridges developmental biology, molecular genetics, and clinical anatomy. He leads a PhD-level research project titled 'Investigation of genes and gene proteins in cleft affected tissue' and actively participates in broader institutional research on craniofacial anomalies. He regularly presents findings at conferences, including oral and poster presentations, and engages in peer review for journals like Tissue and Cell . Latvian Council of Science Expert, Field of Science 3.1 Basic Medicine (2024–2027) He advises doctoral candidates and collaborates with researchers such as Professor Maija Pilmane and Professor Ingrida Akota. His research is supported by RSU internal grants and PhD project funding. He is part of a collaborative network studying tissue remodeling and inflammation in craniofacial anomalies, contributing to a multidisciplinary team that includes experts in histology, immunology, and maxillofacial surgery.

• Osteology
• Biomechanics
• Bone Remodeling
• +5 more

Thorsten Schinke is a full-time faculty member and Professor at the Department of Osteology and Biomechanics , University of Hamburg-Eppendorf (UKE). His research focuses on molecular mechanisms of bone remodeling, Wnt/Notch signaling, osteoimmunology, and genetic factors in skeletal disorders. Key Research Themes: Wnt Signaling, Osteoporosis, Osteoimmunology, Skeletal Metastasis, Genetic Bone Diseases, Osteal Macrophages Scientific Contributions: Schinke has led 8 DFG-funded projects (2010-2021) exploring interactions between bone remodeling and disease states. His work includes identifying novel roles for Rsk2, PLS3, and Notch2 in osteosarcoma progression, X-linked osteoporosis, and Hajdu-Cheney syndrome. Using genetically engineered mouse models, he established connections between cytokine signaling (e.g., IL17, S1P), lysosomal dysfunction, and skeletal pathology. Recent Trends: Analysis of 15 recent publications (2017-2021) reveals expertise in in vivo bone modeling, histomorphometry, and cross-disciplinary approaches combining immunology and bone biology. Key subfields include tumor-bone interactions, Wnt-stimulated anabolism, and metabolic regulation of osteoblast/osteoclast balance. Scientific Awards: DFG Project 401122336 (2018-2021) DFG Project 385501541 (2017-2021) DFG Project 278045702 (2015-2019) DFG Project 235869912 (2013-2017) DFG Project 27463524 (2010-2014) Contact: Research conducted at Campus Lehre N55, Martinistrasse 52, Hamburg. Email: fis@uke.de

Christina Møller AndreasenView profile

Associate Professor

• Bone Biology
• Osteoporosis
• Bone Remodeling
• +2 more

Christina Møller Andreasen is an Associate Professor at the Research Unit of Pathology at the University of Southern Denmark. Her research focuses on bone biology, particularly in areas such as osteoporosis, bone remodeling, and translational pathology. She has published over 80 works and actively participates in academic activities including teaching, supervision, and international collaborations.

Jerrod Heath SeifertView profile

Associate Professor

• Archaeological Conservation
• Heritage Management
• Corrosion Science
• +3 more

Jerrod Heath Seifert is an Associate Professor in Conservation at the University of Oslo's Faculty of Humanities, within the Department of Archaeology, Conservation and History. His work focuses on the preservation and management of archaeological cultural heritage, particularly archaeological sites and metals. He earned his PhD in Conservation Science (2021) from Cardiff University, with a thesis on cast iron cannonball corrosion on the Mary Rose. Education: PhD in Conservation Science, Cardiff University (2021) MSc in Conservation Practice, Cardiff University (2015) BA in Classical & Near Eastern Archaeology and Art History, University of Minnesota (2006) Research Interests: Specializing in archaeological site stabilization, corrosion science of metals, and heritage conservation management. He co-leads the Vésztő-Mágor Conservation Project in Hungary, addressing in-situ site preservation. His work integrates environmental science and innovative techniques to safeguard earthen heritage. Teaching: Leads courses in conservation science, ethics, and material conservation, including KONS1000 (Introduction to Conservation), KONS4036/4037 (Organic Material Conservation), and KONS4050 (Analytical Methods). Advising & Grants: Supervises PhD students Magnihild Aasen (lead) and Ruben With (co). His research has been published in venues like European Physical Journal Plus and Journal of Field Archaeology , focusing on corrosion studies, site management, and heritage innovation. Labs/Teams: Active in the Vésztő-Mágor multinational team and collaborates on projects integrating conservation science with archaeological practice.

• Bone Metabolism
• Osteoporosis
• Atypical Femur Fractures
• +7 more

Hanh Nguyen is a Research Fellow at the Faculty of Medicine, Monash University, affiliated with Monash Health. Her work is focused on clinical and translational research in bone metabolism, particularly atypical femur fractures, osteoporosis, and related endocrine disorders. Her research interests span bone biomechanics , genetics of bone diseases , hypophosphatasia , and the application of deep learning in medical imaging for fracture detection. She employs advanced methodologies in radiographic analysis and patient cohort studies to improve diagnosis and understanding of skeletal disorders. The recent publications highlight a strong trend in integrating AI-driven diagnostics with clinical endocrinology , particularly in identifying atypical fractures and metabolic bone conditions. Her work bridges computational innovation with patient-centered outcomes, contributing to both technological and clinical advancements. No scientific awards are explicitly mentioned in the provided text. Hanh Nguyen actively collaborates with leading researchers such as Professor Peter R. Ebeling, Dr. Christian Girgis, and Professor Roland Zebaze. While no formal students or grant details are listed, her consistent output in high-impact journals suggests active involvement in research mentoring and project leadership within the Monash endocrinology research group. She is part of a broader research network focused on bone health and endocrine disorders at Monash, contributing to UN Sustainable Development Goals related to good health and well-being. Her team leverages clinical data, imaging, and genetic analysis to advance understanding of skeletal fragility and metabolic bone diseases.

• Childhood Bone Diseases
• Skeletal Development
• Metabolic Bone Diseases
• +3 more

Dr. Frank Rauch serves as Associate Professor in the Department of Pediatrics at the University of Montreal's Faculty of Medicine, based at CHU Sainte-Justine in Montreal. His dual institutional affiliation extends to Shriners Hospital for Children through McGill University, where he conducts specialized research in pediatric skeletal disorders. His academic foundation includes: Medical studies at Technical University of Munich (1987-1991) Pediatric residency at University Children's Hospital of Cologne (1992-1997) Fellowship in Metabolic Bone Diseases at Shriners Hospital for Children, Montreal (1997-1998) Dr. Rauch's research program investigates skeletal development pathways and the molecular mechanisms underlying genetic bone diseases, with particular focus on osteogenesis imperfecta and rare metabolic disorders. His translational work bridges clinical observations with laboratory investigations to characterize disease phenotypes and identify therapeutic targets. Analysis of his 73 publications since 2011 reveals consistent emphasis on genetic mutations affecting bone formation, with recent studies exploring SPARC, P4HB, BMP1, and PLS3 gene variants. His work demonstrates strong interdisciplinary collaboration across genetics, orthopedics, and molecular biology. Professional recognition includes: FRQS Clinical Research Fellowship (held continuously since 2004) Dr. Rauch maintains active research funding through two major grants from CIHR and NIH. His scholarly impact is further demonstrated by 14 international conference presentations since 2011, establishing him as a recognized expert in pediatric bone pathology. He operates within CHU Sainte-Justine's research ecosystem, collaborating with multidisciplinary teams including geneticists, orthopedic surgeons, and bone biologists to advance understanding of childhood skeletal disorders through integrated clinical and laboratory approaches.

Christopher H. EvansView profile

Professor

• Gene Therapy
• Musculoskeletal Biology
• Osteoarthritis
• +7 more

Christopher H. Evans, Ph.D., is a Professor at Mayo Clinic College of Medicine and Science, with primary appointments in the Department of Physical Medicine & Rehabilitation and joint appointments in the Department of Orthopedic Surgery and Department of Molecular Medicine at Mayo Clinic, Rochester, Minnesota. He holds the distinguished title of John and Posy Krehbiel Professor of Orthopedics and serves as Director of the Rehabilitation Medicine Research Center and Principal Investigator of the Musculoskeletal Gene Therapy Research Laboratory. John and Posy Krehbiel Professor of Orthopedics (2019) President, Orthopaedic Research Society (2004–2005) Marshall R. Urist, MD Award (2009) Arthur Steindler, MD Award (2010) Honorary Fellow, Swansea University (2009) Dr. Evans’ research leverages gene therapy to develop novel treatments for osteoarthritis and musculoskeletal tissue regeneration. His work spans from basic molecular biology to clinical translation, with a focus on intra-articular gene delivery, bone healing, and cartilage repair. He investigates how inflammatory mediators like IL-1β affect stem cell differentiation and tissue regeneration, aiming to modulate these pathways for therapeutic benefit. The recent publication trends highlight a strong focus on gene therapy for arthritis, particularly using IL-1Ra and BMP-2, as well as innovative approaches like chemically modified RNA and mechanical modulation for bone healing. His studies span preclinical models to human clinical trials, demonstrating a robust translational pipeline. Key themes include chondrocyte senescence, matrix stiffness, epigenetic regulation, and dual-gene delivery systems. Dr. Evans has secured significant research funding, including grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Congressionally Directed Medical Research Programs. His laboratory actively mentors postdoctoral fellows and collaborates on multidisciplinary projects aimed at improving outcomes in orthopedics and rehabilitation medicine. His lab, the Musculoskeletal Gene Therapy Research Laboratory, is at the forefront of developing single-operation, gene-based therapies for osteoarthritis and non-healing fractures, with the goal of reducing disability and healthcare costs. The lab’s work integrates molecular biology, biomechanics, and clinical research to advance regenerative orthobiologics.

Enrico Dall'AraView profile

Professor

• Biomechanics
• Computational Modeling in Medicine
• Musculoskeletal Tissue Mechanics
• +6 more

Professor Enrico Dall'Ara is a leading figure in musculoskeletal biomechanics at the University of Sheffield , where he holds the Professorship of Musculoskeletal Biomechanics since 2024. He directs the Skelet.Al Laboratories , serves as Research Director for Insigneo's Computational Modelling in Medicine theme, and leads the Non-Clinical Task Force in the Avicenna Alliance. Education: PhD in Biomechanics (Vienna), MSc Mechanical Engineering (Bologna) Current Roles: President of European Society of Biomechanics, Deputy Head of IMSB Research Group Research Focus: Subject-specific computational models for bone strength prediction, fracture risk assessment, and mechanobiological studies in preclinical/clinical settings. Key applications include osteoporosis , osteoarthritis , and vertebral metastases , integrating imaging , experimental , and computational methods . Recent Article Trends: His computational work spans finite element modeling , digital volume correlation , machine learning in segmentation , and multi-scale adaptation studies , validated through microCT , synchrotron tomography , and MR imaging across mouse models and human specimens . Scientific Awards & Leadership: President, European Society of Biomechanics (2024) Director, Skelet.Al Laboratories (2020) Research Director, Insigneo (2021) Council Member, Avicenna Alliance (2023) Editorial roles in Journal of Mechanical Behaviour and Frontiers in Bioengineering Advising & Grants: Mentors 14+ PhD students across international institutions. Secured £2.6M+ in grants including EPSRC Virtual Human Twin (£1.74M), Horizon Europe METASTRA (£773k), and EUROSTARS projects. Collaborates with EPSRC, Horizon2020, and AO Spine.

Alev CumbulView profile

Assistant Professor

• Histology
• Developmental Biology
• Tissue Engineering
• +4 more

Dr. Alev Cumbul is an Assistant Professor in the Department of Histology & Embryology at Yeditepe University Faculty of Medicine, where she has been since 2011. Her research focuses on tissue engineering, wound healing mechanisms, and molecular pathways in degenerative diseases. PhD in Histology & Embryology (Eskişehir Osmangazi University, 2003-2008) BSc in Veterinary Medicine (Ankara University, 1995-2001) Her scientific work spans histopathology , apoptosis , neuroprotection , and biomaterials development . Recent publications examine pomegranate seed oil's protective effects against colitis-related organ damage and nanoparticle-based wound healing formulations. She supervises graduate students in projects exploring polycystic ovary syndrome and neurodegenerative models . As a principal investigator in multiple funded projects (e.g., TÜBİTAK grants), she has developed novel scaffolds for bone regeneration and evaluated antioxidant therapies. Her 15 most recent articles reveal consistent focus on VEGF signaling , oxidative stress , and stem cell applications across cardiovascular , neurological , and gastrointestinal models. 2024: Poster Mansiyon Award (Yeditepe University) 2022: Best Poster Award (Yeditepe University)

Cheryl QuennevilleView profile

Associate Professor

• Biomechanics
• Biomedical Engineering
• Biomaterials
• +8 more

Dr. Cheryl Quenneville is an Associate Professor in the Department of Mechanical Engineering at McMaster University and an Associate Member of the School of Biomedical Engineering. She specializes in biomechanics and biomedical engineering with a focus on injury tolerance criteria, orthopaedic device design, and computational modeling. Education: B.A.Sc. (Queen's University, 2003), M.Sc. (Western University, 2005), Ph.D. (Western University, 2009) Current Role: Associate Chair, Undergraduate, Mechanical Engineering Her research program integrates experimental testing and finite element modeling to advance understanding of bone fracture mechanics, develop injury risk functions, and validate synthetic surrogates for biomechanical research. Recent work has addressed hockey neck guard safety, forearm injury limits, and hip fracture risk prediction using DXA imaging. Key trends in her publications include injury biomechanics, computational modeling, and medical imaging applications. She has received the Petro-Canada-McMaster Young Innovator Award and collaborates with industry partners like Niko Apparel Systems. Her lab emphasizes trainee development and translation of findings to clinical and industrial partners. Scientific Awards: Petro-Canada-McMaster Young Innovator Award Dr. Quenneville teaches Current Topics in Orthopaedic Biomechanics (MECHENG 717/BIOMED 717) and actively accepts graduate students. The McMaster Injury Biomechanics Lab, which she leads, develops comprehensive injury limits for understudied events and translates findings through partnerships in healthcare and safety industries.

• Bone Biology
• Osteoclast Biology
• Multiple Myeloma
• +5 more

Dr. Michelle McDonald is a Senior Lecturer in the School of Medical Sciences within the Faculty of Medicine and Health at the University of Sydney. Her research program focuses on skeletal biology with particular emphasis on bone metastasis, osteoclast biology, and multiple myeloma bone disease. Dr. McDonald's research interests span bone biology, osteoporosis, multiple myeloma, and bone metastasis. Her work has significantly advanced our understanding of osteoclast biology, particularly regarding osteoclast recycling through osteomorphs and the rebound phenomenon following denosumab discontinuation. She has pioneered research on bone imaging techniques, developing minimally invasive approaches to visualize cellular dynamics in intact long bone and single-cell resolution imaging of tumor cells in bone. Analysis of her recent publications reveals a strong focus on translational bone research with significant contributions to understanding the mechanisms of bone metastasis, particularly in breast cancer and multiple myeloma. Her work on osteomorphs has opened new avenues for therapeutic intervention in bone diseases. Her 2024 publications demonstrate continued innovation in bone imaging technologies and computational approaches to understanding bone diseases. Dr. McDonald has secured significant research funding including NIH grants for bone-targeted therapies to improve bone health and prevent relapse in multiple myeloma, as well as targeted funding from Tour de Cure Ltd for research on the skeleton as a reservoir for metastatic tumor cells in breast cancer. Her research program involves extensive collaboration with leading bone researchers internationally and utilizes advanced imaging technologies to investigate cellular dynamics in bone. She is actively contributing to the development of new therapeutic approaches for bone diseases and metastatic cancers that affect bone.